Previously, we have demonstrated that SOX17 overexpression could sensitize the resistant ESCC cells to CCRT treatment through transcriptional suppression of DNA repair and damage response genes [24]. This evidence concerns the gene SOX17 and esophageal squamous cell carcinoma.